1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope
2. Executive Summary
2.1. Market Snapshot: Global Checkpoint Inhibitor Refractory Cancer Market
2.2. Global Checkpoint Inhibitor Refractory Cancer Market, By Type
2.3. Global Checkpoint Inhibitor Refractory Cancer Market, By Application
2.4. Global Checkpoint Inhibitor Refractory Cancer Market, By Region
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Checkpoint Inhibitor Refractory Cancer Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Application
3.5.2. Type
3.5.3. Geography
4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend
5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Type Launch
5.5.5. Geographical Expansion
5.5.6. Others
6. COVID 19 Impact Analysis
6.1. Global Checkpoint Inhibitor Refractory Cancer Market Pre Vs Post COVID 19, 2022 – 2030
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply
7. Global Checkpoint Inhibitor Refractory Cancer Market
7.1. Global Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030(US$ Bn)
7.1.1. Overview
7.1.2. Global Checkpoint Inhibitor Refractory Cancer Market, By Type, 2022 vs 2030 (in%)
7.1.3. Global Checkpoint Inhibitor Refractory Cancer Market, By CTLA-4 Inhibitor, 2017-2030 (US$ Bn)
7.1.4. Global Checkpoint Inhibitor Refractory Cancer Market, By PD-1 Inhibitor, 2017-2030 (US$ Bn)
7.1.5. Global Checkpoint Inhibitor Refractory Cancer Market, By PD-L1 Inhibitor, 2017-2030 (US$ Bn)
7.1.6. Global Checkpoint Inhibitor Refractory Cancer Market, By Others, 2017-2030 (US$ Bn)
7.2. Global Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030(US$ Bn)
7.2.1. Overview
7.2.2. Global Checkpoint Inhibitor Refractory Cancer Market, By Application, 2022 vs 2030 (in%)
7.2.3. Global Checkpoint Inhibitor Refractory Cancer Market, By Lung Cancer, 2017-2030 (US$ Bn)
7.2.4. Global Checkpoint Inhibitor Refractory Cancer Market, By Bladder Cancer, 2017-2030 (US$ Bn)
7.2.5. Global Checkpoint Inhibitor Refractory Cancer Market, By Others, 2017-2030 (US$ Bn)
8. North America Checkpoint Inhibitor Refractory Cancer Market Analysis
8.1. North America Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
8.3.1. U.S.
8.3.1.1. U.S. Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.3.1.2. U.S. Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
8.3.1.3. U.S. Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
8.3.2. Canada
8.3.2.1. Canada Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
8.3.2.2. Canada Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
9. Europe Checkpoint Inhibitor Refractory Cancer Market Analysis
9.1. Europe Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
9.3.1. Germany
9.3.1.1. Germany Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.1.2. Germany Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
9.3.1.3. Germany Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
9.3.2. France
9.3.2.1. France Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.2.2. France Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
9.3.2.3. France Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
9.3.3. UK
9.3.3.1. UK Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.3.2. UK Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
9.3.3.3. UK Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
9.3.4. Italy
9.3.4.1. Italy Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.4.2. Italy Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
9.3.4.3. Italy Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
9.3.5. Spain
9.3.5.1. Spain Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.5.2. Spain Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
9.3.5.3. Spain Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
9.3.6. Rest of Europe
9.3.6.1. Rest of Europe Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.3.6.2. Rest of Europe Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
9.3.6.3. Rest of Europe Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
10. Asia Pacific Checkpoint Inhibitor Refractory Cancer Market Analysis
10.1. Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
10.3.1. China
10.3.1.1. China Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.1.2. China Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
10.3.1.3. China Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
10.3.2. Japan
10.3.2.1. Japan Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. Japan Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
10.3.2.3. Japan Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
10.3.3. India
10.3.3.1. India Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. India Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
10.3.3.3. India Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
10.3.4. South Korea
10.3.4.1. South Korea Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. South Korea Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
10.3.4.3. South Korea Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
10.3.5. South-East Asia
10.3.5.1. South-East Asia Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.5.2. South-East Asia Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
10.3.5.3. South-East Asia Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
10.3.6. Rest of Asia Pacific
10.3.6.1. Rest of Asia Pacific Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.6.2. Rest of Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
10.3.6.3. Rest of Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
11. Latin America Checkpoint Inhibitor Refractory Cancer Market Analysis
11.1. Latin America Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Brazil
11.3.1.1. Brazil Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.1.2. Brazil Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
11.3.1.3. Brazil Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
11.3.2. Mexico
11.3.2.1. Mexico Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Mexico Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
11.3.2.3. Mexico Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
11.3.3. Rest of Latin America
11.3.3.1. Rest of Latin America Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. Rest of Latin America Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
11.3.3.3. Rest of Latin America Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
12. Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market Analysis
12.1. Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
12.3.1. GCC Countries
12.3.1.1. GCC Countries Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.1.2. GCC Countries Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
12.3.1.3. GCC Countries Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
12.3.2. South Africa
12.3.2.1. South Africa Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. South Africa Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
12.3.2.3. South Africa Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
12.3.3. Rest of Middle East and Africa
12.3.3.1. Rest of Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Rest of Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
12.3.3.3. Rest of Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
13. Company Profiles
13.1. 4D PHARMA PLC
13.1.1. Company Overview
13.1.2. Types/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. 4SC AG
13.3. ASCENTAGE PHARMA GROUP
13.4. EISAI INC
13.5. Bristol-Myers Squibb
13.6. AstraZeneca
13.7. Merck
13.8. Others
List of Figures
FIG. 1 Global Checkpoint Inhibitor Refractory Cancer Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Checkpoint Inhibitor Refractory Cancer Market Segmentation
FIG. 4 Global Checkpoint Inhibitor Refractory Cancer Market, By Type, 2022 (US$ Bn)
FIG. 5 Global Checkpoint Inhibitor Refractory Cancer Market, By Application, 2022 (US$ Bn)
FIG. 6 Global Checkpoint Inhibitor Refractory Cancer Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, By Type, 2022
FIG. 8 Attractive Investment Proposition, By Application, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Checkpoint Inhibitor Refractory Cancer Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Checkpoint Inhibitor Refractory Cancer Market Manufacturers, 2022
FIG. 12 Global Checkpoint Inhibitor Refractory Cancer Market Value Contribution, By Type, 2022 & 2028 (Value %)
FIG. 13 Global Checkpoint Inhibitor Refractory Cancer Market, By CTLA-4 Inhibitor, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Checkpoint Inhibitor Refractory Cancer Market, By PD-1 Inhibitor, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Checkpoint Inhibitor Refractory Cancer Market, By PD-L1 Inhibitor, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Checkpoint Inhibitor Refractory Cancer Market, By Others, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Checkpoint Inhibitor Refractory Cancer Market Value Contribution, By Application, 2022 & 2028 (Value %)
FIG. 18 Global Checkpoint Inhibitor Refractory Cancer Market, By Lung Cancer, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Checkpoint Inhibitor Refractory Cancer Market, By Bladder Cancer, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Checkpoint Inhibitor Refractory Cancer Market, By Others, 2017-2030 (US$ Bn)
FIG. 21 U.S. Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 22 Canada Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 23 Germany Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 24 France Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 25 U.K. Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 26 Italy Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 27 Spain Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 28 Rest of Europe Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 29 China Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 30 Japan Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 31 India Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 32 South Korea Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 33 Southeast Asia Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 34 Rest of Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 35 Latin America Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 36 Brazil Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 37 Mexico Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Latin America Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 39 Middle East & Africa Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 40 GCC Countries Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 41 South Africa Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
FIG. 42 Rest of Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, 2017-2030 (US$ Bn)
List of Tables
TABLE 1 Market Snapshot: Global Checkpoint Inhibitor Refractory Cancer Market
TABLE 2 Global Checkpoint Inhibitor Refractory Cancer Market, by Competitive Benchmarking, 2022
TABLE 3 Global Checkpoint Inhibitor Refractory Cancer Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Checkpoint Inhibitor Refractory Cancer Market, by Key Strategies Analysis, 2022
TABLE 5 Global Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 6 Global Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 7 North America Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 8 North America Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 9 North America Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
TABLE 10 US Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 11 US Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 12 Canada Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 13 Canada Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 14 Europe Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 15 Europe Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 16 Europe Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
TABLE 17 Germany Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 18 Germany Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 19 France Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 20 France Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 21 UK Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 22 UK Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 23 Italy Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 24 Italy Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 25 Spain Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 26 Spain Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 27 Rest of Europe Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 28 Rest of Europe Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 29 Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 30 Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 31 Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
TABLE 32 China Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 33 China Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 34 Japan Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 35 Japan Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 36 India Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 37 India Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 38 South Korea Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 39 South Korea Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 40 South East Asia Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 41 South East Asia Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 42 Rest of Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 43 Rest of Asia Pacific Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 44 Latin America Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 45 Latin America Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 46 Latin America Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
TABLE 47 Brazil Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 48 Brazil Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 49 Mexico Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 50 Mexico Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 51 Rest of Latin America Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 52 Rest of Latin America Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 53 Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 54 Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 55 Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, by Country, 2017-2030 (US$ Bn)
TABLE 56 GCC Countries Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 57 GCC Countries Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 58 South Africa Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 59 South Africa Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)
TABLE 60 Rest of Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Type, 2017-2030 (US$ Bn)
TABLE 61 Rest of Middle East and Africa Checkpoint Inhibitor Refractory Cancer Market, By Application, 2017-2030 (US$ Bn)